nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Skin burning sensation—Niacin—atherosclerosis	0.0256	0.0364	CcSEcCtD
Brimonidine—Common cold—Pravastatin—atherosclerosis	0.0236	0.0336	CcSEcCtD
Brimonidine—Endophthalmitis—Pravastatin—atherosclerosis	0.0129	0.0184	CcSEcCtD
Brimonidine—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.0106	0.0151	CcSEcCtD
Brimonidine—Respiratory tract infection—Pravastatin—atherosclerosis	0.0098	0.0139	CcSEcCtD
Brimonidine—Burning sensation—Niacin—atherosclerosis	0.00901	0.0128	CcSEcCtD
Brimonidine—Eye irritation—Lovastatin—atherosclerosis	0.00853	0.0121	CcSEcCtD
Brimonidine—Glaucoma—Niacin—atherosclerosis	0.00831	0.0118	CcSEcCtD
Brimonidine—Feeling hot—Niacin—atherosclerosis	0.00797	0.0113	CcSEcCtD
Brimonidine—Cataract—Lovastatin—atherosclerosis	0.00765	0.0109	CcSEcCtD
Brimonidine—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00717	0.0102	CcSEcCtD
Brimonidine—Cataract—Simvastatin—atherosclerosis	0.00716	0.0102	CcSEcCtD
Brimonidine—Cataract—Pravastatin—atherosclerosis	0.00647	0.0092	CcSEcCtD
Brimonidine—Dermatitis contact—Niacin—atherosclerosis	0.00618	0.00879	CcSEcCtD
Brimonidine—Diabetes mellitus—Simvastatin—atherosclerosis	0.00569	0.00809	CcSEcCtD
Brimonidine—Swelling—Simvastatin—atherosclerosis	0.00561	0.00797	CcSEcCtD
Brimonidine—Abnormal vision—Niacin—atherosclerosis	0.00546	0.00776	CcSEcCtD
Brimonidine—Arthritis—Lovastatin—atherosclerosis	0.00544	0.00774	CcSEcCtD
Brimonidine—Influenza—Rosuvastatin—atherosclerosis	0.00539	0.00767	CcSEcCtD
Brimonidine—Arthritis—Ezetimibe—atherosclerosis	0.00534	0.00759	CcSEcCtD
Brimonidine—Diabetes mellitus—Niacin—atherosclerosis	0.00522	0.00742	CcSEcCtD
Brimonidine—Bronchitis—Rosuvastatin—atherosclerosis	0.00519	0.00738	CcSEcCtD
Brimonidine—Arthritis—Simvastatin—atherosclerosis	0.00509	0.00724	CcSEcCtD
Brimonidine—Depression—Rosuvastatin—atherosclerosis	0.0048	0.00682	CcSEcCtD
Brimonidine—Arthritis—Niacin—atherosclerosis	0.00467	0.00665	CcSEcCtD
Brimonidine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00464	0.0066	CcSEcCtD
Brimonidine—Arthritis—Pravastatin—atherosclerosis	0.0046	0.00654	CcSEcCtD
Brimonidine—Influenza—Lovastatin—atherosclerosis	0.00457	0.0065	CcSEcCtD
Brimonidine—Sinusitis—Rosuvastatin—atherosclerosis	0.00451	0.00642	CcSEcCtD
Brimonidine—Influenza—Ezetimibe—atherosclerosis	0.00448	0.00637	CcSEcCtD
Brimonidine—Face oedema—Niacin—atherosclerosis	0.00439	0.00623	CcSEcCtD
Brimonidine—Rhinitis—Rosuvastatin—atherosclerosis	0.00433	0.00615	CcSEcCtD
Brimonidine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00428	0.00609	CcSEcCtD
Brimonidine—Dry skin—Niacin—atherosclerosis	0.00416	0.00592	CcSEcCtD
Brimonidine—Bronchitis—Simvastatin—atherosclerosis	0.00411	0.00585	CcSEcCtD
Brimonidine—Dry skin—Pravastatin—atherosclerosis	0.0041	0.00583	CcSEcCtD
Brimonidine—Nasopharyngitis—Pravastatin—atherosclerosis	0.004	0.00569	CcSEcCtD
Brimonidine—Influenza—Niacin—atherosclerosis	0.00393	0.00558	CcSEcCtD
Brimonidine—Influenza—Pravastatin—atherosclerosis	0.00387	0.0055	CcSEcCtD
Brimonidine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00386	0.00548	CcSEcCtD
Brimonidine—Sinusitis—Lovastatin—atherosclerosis	0.00382	0.00544	CcSEcCtD
Brimonidine—Depression—Simvastatin—atherosclerosis	0.0038	0.0054	CcSEcCtD
Brimonidine—Mental disorder—Rosuvastatin—atherosclerosis	0.00378	0.00538	CcSEcCtD
Brimonidine—Bronchitis—Niacin—atherosclerosis	0.00378	0.00537	CcSEcCtD
Brimonidine—Sinusitis—Ezetimibe—atherosclerosis	0.00375	0.00533	CcSEcCtD
Brimonidine—Sinusitis—Simvastatin—atherosclerosis	0.00358	0.00509	CcSEcCtD
Brimonidine—Pharyngitis—Ezetimibe—atherosclerosis	0.00356	0.00506	CcSEcCtD
Brimonidine—Depression—Pravastatin—atherosclerosis	0.00344	0.00489	CcSEcCtD
Brimonidine—Flushing—Lovastatin—atherosclerosis	0.0034	0.00483	CcSEcCtD
Brimonidine—Flushing—Ezetimibe—atherosclerosis	0.00333	0.00474	CcSEcCtD
Brimonidine—Cough—Rosuvastatin—atherosclerosis	0.00328	0.00466	CcSEcCtD
Brimonidine—Angiopathy—Ezetimibe—atherosclerosis	0.00326	0.00463	CcSEcCtD
Brimonidine—Immune system disorder—Ezetimibe—atherosclerosis	0.00324	0.00461	CcSEcCtD
Brimonidine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00323	0.0046	CcSEcCtD
Brimonidine—Sinusitis—Pravastatin—atherosclerosis	0.00323	0.0046	CcSEcCtD
Brimonidine—Myalgia—Rosuvastatin—atherosclerosis	0.0032	0.00455	CcSEcCtD
Brimonidine—Arthralgia—Rosuvastatin—atherosclerosis	0.0032	0.00455	CcSEcCtD
Brimonidine—Flushing—Simvastatin—atherosclerosis	0.00318	0.00452	CcSEcCtD
Brimonidine—Rhinitis—Niacin—atherosclerosis	0.00315	0.00448	CcSEcCtD
Brimonidine—Mental disorder—Ezetimibe—atherosclerosis	0.00314	0.00447	CcSEcCtD
Brimonidine—Erythema—Ezetimibe—atherosclerosis	0.00312	0.00444	CcSEcCtD
Brimonidine—Dysgeusia—Lovastatin—atherosclerosis	0.00312	0.00443	CcSEcCtD
Brimonidine—Rhinitis—Pravastatin—atherosclerosis	0.0031	0.00441	CcSEcCtD
Brimonidine—Pharyngitis—Pravastatin—atherosclerosis	0.00307	0.00437	CcSEcCtD
Brimonidine—Infection—Rosuvastatin—atherosclerosis	0.00305	0.00433	CcSEcCtD
Brimonidine—Visual impairment—Niacin—atherosclerosis	0.00303	0.00431	CcSEcCtD
Brimonidine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00301	0.00428	CcSEcCtD
Brimonidine—Vision blurred—Lovastatin—atherosclerosis	0.003	0.00427	CcSEcCtD
Brimonidine—Mental disorder—Simvastatin—atherosclerosis	0.003	0.00426	CcSEcCtD
Brimonidine—Visual impairment—Pravastatin—atherosclerosis	0.00298	0.00424	CcSEcCtD
Brimonidine—Erythema—Simvastatin—atherosclerosis	0.00298	0.00424	CcSEcCtD
Brimonidine—Eye disorder—Niacin—atherosclerosis	0.00294	0.00418	CcSEcCtD
Brimonidine—Dysgeusia—Simvastatin—atherosclerosis	0.00292	0.00415	CcSEcCtD
Brimonidine—Flushing—Niacin—atherosclerosis	0.00292	0.00415	CcSEcCtD
Brimonidine—Cardiac disorder—Pravastatin—atherosclerosis	0.00287	0.00408	CcSEcCtD
Brimonidine—Flushing—Pravastatin—atherosclerosis	0.00287	0.00408	CcSEcCtD
Brimonidine—Angiopathy—Niacin—atherosclerosis	0.00285	0.00405	CcSEcCtD
Brimonidine—Vision blurred—Simvastatin—atherosclerosis	0.00281	0.00399	CcSEcCtD
Brimonidine—Arrhythmia—Niacin—atherosclerosis	0.00281	0.00399	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00279	0.00397	CcSEcCtD
Brimonidine—Insomnia—Rosuvastatin—atherosclerosis	0.00277	0.00394	CcSEcCtD
Brimonidine—Arrhythmia—Pravastatin—atherosclerosis	0.00276	0.00393	CcSEcCtD
Brimonidine—Palpitations—Ezetimibe—atherosclerosis	0.00276	0.00393	CcSEcCtD
Brimonidine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00275	0.00392	CcSEcCtD
Brimonidine—Erythema—Niacin—atherosclerosis	0.00274	0.00389	CcSEcCtD
Brimonidine—Cough—Ezetimibe—atherosclerosis	0.00273	0.00388	CcSEcCtD
Brimonidine—Chest pain—Lovastatin—atherosclerosis	0.00271	0.00386	CcSEcCtD
Brimonidine—Myalgia—Lovastatin—atherosclerosis	0.00271	0.00386	CcSEcCtD
Brimonidine—Arthralgia—Lovastatin—atherosclerosis	0.00271	0.00386	CcSEcCtD
Brimonidine—Anxiety—Lovastatin—atherosclerosis	0.0027	0.00384	CcSEcCtD
Brimonidine—Dyspepsia—Rosuvastatin—atherosclerosis	0.0027	0.00384	CcSEcCtD
Brimonidine—Hypertension—Ezetimibe—atherosclerosis	0.0027	0.00383	CcSEcCtD
Brimonidine—Discomfort—Lovastatin—atherosclerosis	0.00268	0.00381	CcSEcCtD
Brimonidine—Chest pain—Ezetimibe—atherosclerosis	0.00266	0.00378	CcSEcCtD
Brimonidine—Myalgia—Ezetimibe—atherosclerosis	0.00266	0.00378	CcSEcCtD
Brimonidine—Arthralgia—Ezetimibe—atherosclerosis	0.00266	0.00378	CcSEcCtD
Brimonidine—Dry mouth—Lovastatin—atherosclerosis	0.00265	0.00377	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00264	0.00376	CcSEcCtD
Brimonidine—Dysgeusia—Pravastatin—atherosclerosis	0.00264	0.00375	CcSEcCtD
Brimonidine—Discomfort—Ezetimibe—atherosclerosis	0.00263	0.00374	CcSEcCtD
Brimonidine—Pain—Rosuvastatin—atherosclerosis	0.00262	0.00373	CcSEcCtD
Brimonidine—Dry mouth—Ezetimibe—atherosclerosis	0.0026	0.0037	CcSEcCtD
Brimonidine—Infection—Lovastatin—atherosclerosis	0.00258	0.00367	CcSEcCtD
Brimonidine—Vision blurred—Niacin—atherosclerosis	0.00258	0.00367	CcSEcCtD
Brimonidine—Vision blurred—Pravastatin—atherosclerosis	0.00254	0.00361	CcSEcCtD
Brimonidine—Myalgia—Simvastatin—atherosclerosis	0.00254	0.00361	CcSEcCtD
Brimonidine—Arthralgia—Simvastatin—atherosclerosis	0.00254	0.00361	CcSEcCtD
Brimonidine—Chest pain—Simvastatin—atherosclerosis	0.00254	0.00361	CcSEcCtD
Brimonidine—Infection—Ezetimibe—atherosclerosis	0.00253	0.0036	CcSEcCtD
Brimonidine—Anxiety—Simvastatin—atherosclerosis	0.00253	0.00359	CcSEcCtD
Brimonidine—Discomfort—Simvastatin—atherosclerosis	0.00251	0.00356	CcSEcCtD
Brimonidine—Nervous system disorder—Ezetimibe—atherosclerosis	0.0025	0.00355	CcSEcCtD
Brimonidine—Skin disorder—Ezetimibe—atherosclerosis	0.00248	0.00352	CcSEcCtD
Brimonidine—Syncope—Niacin—atherosclerosis	0.00245	0.00349	CcSEcCtD
Brimonidine—Oedema—Simvastatin—atherosclerosis	0.00243	0.00346	CcSEcCtD
Brimonidine—Palpitations—Niacin—atherosclerosis	0.00242	0.00344	CcSEcCtD
Brimonidine—Infection—Simvastatin—atherosclerosis	0.00242	0.00343	CcSEcCtD
Brimonidine—Loss of consciousness—Niacin—atherosclerosis	0.0024	0.00342	CcSEcCtD
Brimonidine—Cough—Niacin—atherosclerosis	0.00239	0.00339	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00237	0.00337	CcSEcCtD
Brimonidine—Insomnia—Lovastatin—atherosclerosis	0.00235	0.00334	CcSEcCtD
Brimonidine—Cough—Pravastatin—atherosclerosis	0.00235	0.00334	CcSEcCtD
Brimonidine—Paraesthesia—Lovastatin—atherosclerosis	0.00233	0.00332	CcSEcCtD
Brimonidine—Myalgia—Niacin—atherosclerosis	0.00233	0.00331	CcSEcCtD
Brimonidine—Arthralgia—Niacin—atherosclerosis	0.00233	0.00331	CcSEcCtD
Brimonidine—Hypertension—Pravastatin—atherosclerosis	0.00233	0.00331	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00232	0.0033	CcSEcCtD
Brimonidine—Dyspnoea—Lovastatin—atherosclerosis	0.00232	0.00329	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00231	0.00329	CcSEcCtD
Brimonidine—Insomnia—Ezetimibe—atherosclerosis	0.00231	0.00328	CcSEcCtD
Brimonidine—Myalgia—Pravastatin—atherosclerosis	0.00229	0.00326	CcSEcCtD
Brimonidine—Arthralgia—Pravastatin—atherosclerosis	0.00229	0.00326	CcSEcCtD
Brimonidine—Chest pain—Pravastatin—atherosclerosis	0.00229	0.00326	CcSEcCtD
Brimonidine—Paraesthesia—Ezetimibe—atherosclerosis	0.00229	0.00325	CcSEcCtD
Brimonidine—Dyspepsia—Lovastatin—atherosclerosis	0.00229	0.00325	CcSEcCtD
Brimonidine—Anxiety—Pravastatin—atherosclerosis	0.00229	0.00325	CcSEcCtD
Brimonidine—Dry mouth—Niacin—atherosclerosis	0.00228	0.00324	CcSEcCtD
Brimonidine—Dyspnoea—Ezetimibe—atherosclerosis	0.00227	0.00323	CcSEcCtD
Brimonidine—Discomfort—Pravastatin—atherosclerosis	0.00227	0.00322	CcSEcCtD
Brimonidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00226	0.00321	CcSEcCtD
Brimonidine—Dyspepsia—Ezetimibe—atherosclerosis	0.00224	0.00319	CcSEcCtD
Brimonidine—Fatigue—Lovastatin—atherosclerosis	0.00224	0.00319	CcSEcCtD
Brimonidine—Oedema—Niacin—atherosclerosis	0.00223	0.00317	CcSEcCtD
Brimonidine—Pain—Lovastatin—atherosclerosis	0.00222	0.00316	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00222	0.00315	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0022	0.00313	CcSEcCtD
Brimonidine—Asthenia—Rosuvastatin—atherosclerosis	0.0022	0.00313	CcSEcCtD
Brimonidine—Insomnia—Simvastatin—atherosclerosis	0.0022	0.00313	CcSEcCtD
Brimonidine—Oedema—Pravastatin—atherosclerosis	0.0022	0.00313	CcSEcCtD
Brimonidine—Fatigue—Ezetimibe—atherosclerosis	0.0022	0.00313	CcSEcCtD
Brimonidine—Shock—Niacin—atherosclerosis	0.0022	0.00312	CcSEcCtD
Brimonidine—Infection—Pravastatin—atherosclerosis	0.00218	0.0031	CcSEcCtD
Brimonidine—Paraesthesia—Simvastatin—atherosclerosis	0.00218	0.0031	CcSEcCtD
Brimonidine—Pain—Ezetimibe—atherosclerosis	0.00218	0.0031	CcSEcCtD
Brimonidine—Tachycardia—Niacin—atherosclerosis	0.00218	0.0031	CcSEcCtD
Brimonidine—Pruritus—Rosuvastatin—atherosclerosis	0.00217	0.00309	CcSEcCtD
Brimonidine—Skin disorder—Niacin—atherosclerosis	0.00217	0.00308	CcSEcCtD
Brimonidine—Dyspnoea—Simvastatin—atherosclerosis	0.00217	0.00308	CcSEcCtD
Brimonidine—Dyspepsia—Simvastatin—atherosclerosis	0.00214	0.00304	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0021	0.00298	CcSEcCtD
Brimonidine—Fatigue—Simvastatin—atherosclerosis	0.0021	0.00298	CcSEcCtD
Brimonidine—Hypotension—Niacin—atherosclerosis	0.00209	0.00297	CcSEcCtD
Brimonidine—Pain—Simvastatin—atherosclerosis	0.00208	0.00296	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00203	0.00289	CcSEcCtD
Brimonidine—Dizziness—Rosuvastatin—atherosclerosis	0.00203	0.00288	CcSEcCtD
Brimonidine—Insomnia—Niacin—atherosclerosis	0.00202	0.00287	CcSEcCtD
Brimonidine—Paraesthesia—Niacin—atherosclerosis	0.002	0.00285	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.002	0.00285	CcSEcCtD
Brimonidine—Dyspnoea—Niacin—atherosclerosis	0.00199	0.00283	CcSEcCtD
Brimonidine—Insomnia—Pravastatin—atherosclerosis	0.00199	0.00283	CcSEcCtD
Brimonidine—Somnolence—Niacin—atherosclerosis	0.00198	0.00282	CcSEcCtD
Brimonidine—Paraesthesia—Pravastatin—atherosclerosis	0.00197	0.00281	CcSEcCtD
Brimonidine—Dyspepsia—Niacin—atherosclerosis	0.00197	0.00279	CcSEcCtD
Brimonidine—Dyspnoea—Pravastatin—atherosclerosis	0.00196	0.00279	CcSEcCtD
Brimonidine—Dyspepsia—Pravastatin—atherosclerosis	0.00193	0.00275	CcSEcCtD
Brimonidine—Rash—Rosuvastatin—atherosclerosis	0.00193	0.00275	CcSEcCtD
Brimonidine—Dermatitis—Rosuvastatin—atherosclerosis	0.00193	0.00275	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00193	0.00274	CcSEcCtD
Brimonidine—Headache—Rosuvastatin—atherosclerosis	0.00192	0.00273	CcSEcCtD
Brimonidine—Hypersensitivity—Lovastatin—atherosclerosis	0.00192	0.00272	CcSEcCtD
Brimonidine—Pain—Niacin—atherosclerosis	0.00191	0.00271	CcSEcCtD
Brimonidine—Fatigue—Pravastatin—atherosclerosis	0.0019	0.00269	CcSEcCtD
Brimonidine—Pain—Pravastatin—atherosclerosis	0.00188	0.00267	CcSEcCtD
Brimonidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00188	0.00267	CcSEcCtD
Brimonidine—Asthenia—Lovastatin—atherosclerosis	0.00186	0.00265	CcSEcCtD
Brimonidine—Pruritus—Lovastatin—atherosclerosis	0.00184	0.00261	CcSEcCtD
Brimonidine—Asthenia—Ezetimibe—atherosclerosis	0.00183	0.0026	CcSEcCtD
Brimonidine—Nausea—Rosuvastatin—atherosclerosis	0.00182	0.00259	CcSEcCtD
Brimonidine—Pruritus—Ezetimibe—atherosclerosis	0.0018	0.00256	CcSEcCtD
Brimonidine—Hypersensitivity—Simvastatin—atherosclerosis	0.00179	0.00255	CcSEcCtD
Brimonidine—Asthenia—Simvastatin—atherosclerosis	0.00174	0.00248	CcSEcCtD
Brimonidine—Pruritus—Simvastatin—atherosclerosis	0.00172	0.00245	CcSEcCtD
Brimonidine—Dizziness—Lovastatin—atherosclerosis	0.00172	0.00244	CcSEcCtD
Brimonidine—Dizziness—Ezetimibe—atherosclerosis	0.00169	0.0024	CcSEcCtD
Brimonidine—Hypersensitivity—Niacin—atherosclerosis	0.00164	0.00234	CcSEcCtD
Brimonidine—Rash—Lovastatin—atherosclerosis	0.00164	0.00233	CcSEcCtD
Brimonidine—Dermatitis—Lovastatin—atherosclerosis	0.00164	0.00233	CcSEcCtD
Brimonidine—Headache—Lovastatin—atherosclerosis	0.00163	0.00232	CcSEcCtD
Brimonidine—Hypersensitivity—Pravastatin—atherosclerosis	0.00162	0.0023	CcSEcCtD
Brimonidine—Dizziness—Simvastatin—atherosclerosis	0.00161	0.00229	CcSEcCtD
Brimonidine—Rash—Ezetimibe—atherosclerosis	0.00161	0.00229	CcSEcCtD
Brimonidine—Dermatitis—Ezetimibe—atherosclerosis	0.00161	0.00228	CcSEcCtD
Brimonidine—Asthenia—Niacin—atherosclerosis	0.0016	0.00228	CcSEcCtD
Brimonidine—Headache—Ezetimibe—atherosclerosis	0.0016	0.00227	CcSEcCtD
Brimonidine—Pruritus—Niacin—atherosclerosis	0.00158	0.00225	CcSEcCtD
Brimonidine—Asthenia—Pravastatin—atherosclerosis	0.00158	0.00224	CcSEcCtD
Brimonidine—Pruritus—Pravastatin—atherosclerosis	0.00156	0.00221	CcSEcCtD
Brimonidine—Nausea—Lovastatin—atherosclerosis	0.00154	0.0022	CcSEcCtD
Brimonidine—Rash—Simvastatin—atherosclerosis	0.00153	0.00218	CcSEcCtD
Brimonidine—Dermatitis—Simvastatin—atherosclerosis	0.00153	0.00218	CcSEcCtD
Brimonidine—Headache—Simvastatin—atherosclerosis	0.00152	0.00217	CcSEcCtD
Brimonidine—Nausea—Ezetimibe—atherosclerosis	0.00151	0.00215	CcSEcCtD
Brimonidine—Dizziness—Niacin—atherosclerosis	0.00148	0.0021	CcSEcCtD
Brimonidine—Dizziness—Pravastatin—atherosclerosis	0.00145	0.00207	CcSEcCtD
Brimonidine—Nausea—Simvastatin—atherosclerosis	0.00144	0.00205	CcSEcCtD
Brimonidine—Rash—Niacin—atherosclerosis	0.00141	0.002	CcSEcCtD
Brimonidine—Dermatitis—Niacin—atherosclerosis	0.00141	0.002	CcSEcCtD
Brimonidine—Headache—Niacin—atherosclerosis	0.0014	0.00199	CcSEcCtD
Brimonidine—Rash—Pravastatin—atherosclerosis	0.00139	0.00197	CcSEcCtD
Brimonidine—Dermatitis—Pravastatin—atherosclerosis	0.00138	0.00197	CcSEcCtD
Brimonidine—Headache—Pravastatin—atherosclerosis	0.00138	0.00196	CcSEcCtD
Brimonidine—Nausea—Niacin—atherosclerosis	0.00133	0.00189	CcSEcCtD
Brimonidine—Nausea—Pravastatin—atherosclerosis	0.00131	0.00186	CcSEcCtD
Brimonidine—ADRA2C—GPCR downstream signaling—AGT—atherosclerosis	0.000128	0.000432	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LIPC—atherosclerosis	0.000128	0.000431	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOC3—atherosclerosis	0.000127	0.000428	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL3—atherosclerosis	0.000127	0.000428	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—F2—atherosclerosis	0.000127	0.000427	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SERPINE1—atherosclerosis	0.000127	0.000427	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000127	0.000427	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS2—atherosclerosis	0.000127	0.000426	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ALB—atherosclerosis	0.000126	0.000426	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LDLR—atherosclerosis	0.000126	0.000426	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—EDN1—atherosclerosis	0.000125	0.000423	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AGT—atherosclerosis	0.000125	0.00042	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000124	0.000419	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CETP—atherosclerosis	0.000123	0.000416	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EDNRA—atherosclerosis	0.000123	0.000414	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR2—atherosclerosis	0.000123	0.000414	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ABCA1—atherosclerosis	0.000122	0.000413	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CYBA—atherosclerosis	0.000122	0.000413	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NCF1—atherosclerosis	0.000122	0.00041	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000121	0.000409	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS3—atherosclerosis	0.000121	0.000407	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CNR2—atherosclerosis	0.00012	0.000404	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCL8—atherosclerosis	0.00012	0.000404	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GHRL—atherosclerosis	0.00012	0.000404	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PARP1—atherosclerosis	0.00012	0.000404	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PLAT—atherosclerosis	0.00012	0.000404	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—MMP3—atherosclerosis	0.00012	0.000403	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—F2—atherosclerosis	0.000118	0.000399	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000118	0.000399	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—SCARB1—atherosclerosis	0.000118	0.000398	CbGpPWpGaD
Brimonidine—AOX1—Disease—STAT3—atherosclerosis	0.000118	0.000397	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AGT—atherosclerosis	0.000116	0.000392	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—F2—atherosclerosis	0.000115	0.000388	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EDNRA—atherosclerosis	0.000115	0.000387	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR2—atherosclerosis	0.000115	0.000387	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—VEGFA—atherosclerosis	0.000115	0.000387	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CYBA—atherosclerosis	0.000114	0.000385	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EDN1—atherosclerosis	0.000114	0.000384	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000113	0.000382	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL5—atherosclerosis	0.000113	0.000381	CbGpPWpGaD
Brimonidine—AOX1—Disease—MAPK3—atherosclerosis	0.000113	0.000379	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GHRL—atherosclerosis	0.000112	0.000377	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PARP1—atherosclerosis	0.000112	0.000377	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PLAT—atherosclerosis	0.000112	0.000377	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMGCR—atherosclerosis	0.000112	0.000376	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PIK3CG—atherosclerosis	0.00011	0.000371	CbGpPWpGaD
Brimonidine—AOX1—Disease—TGFB1—atherosclerosis	0.000109	0.000368	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—MAPK3—atherosclerosis	0.000109	0.000366	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000108	0.000363	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—F2—atherosclerosis	0.000107	0.000362	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	0.000107	0.000362	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—VEGFA—atherosclerosis	0.000107	0.000361	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	0.000107	0.00036	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	0.000106	0.000358	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	0.000106	0.000356	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TGFB1—atherosclerosis	0.000105	0.000355	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	0.000105	0.000355	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HMOX1—atherosclerosis	0.000105	0.000354	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	0.000105	0.000352	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000104	0.000351	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	0.000103	0.000348	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PIK3CG—atherosclerosis	0.000103	0.000347	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	0.000103	0.000346	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PLG—atherosclerosis	0.000102	0.000343	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—MAPK3—atherosclerosis	0.000101	0.000342	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOB—atherosclerosis	0.000101	0.000339	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ABCA1—atherosclerosis	9.94e-05	0.000335	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	9.88e-05	0.000333	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TGFB1—atherosclerosis	9.84e-05	0.000332	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KNG1—atherosclerosis	9.82e-05	0.000331	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTM1—atherosclerosis	9.79e-05	0.00033	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGTR1—atherosclerosis	9.77e-05	0.000329	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	9.65e-05	0.000325	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	9.61e-05	0.000324	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—LPL—atherosclerosis	9.61e-05	0.000324	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCL2—atherosclerosis	9.58e-05	0.000323	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PLG—atherosclerosis	9.52e-05	0.000321	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	9.45e-05	0.000319	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GPX1—atherosclerosis	9.37e-05	0.000316	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	9.33e-05	0.000314	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	9.33e-05	0.000314	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	9.32e-05	0.000314	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	9.29e-05	0.000313	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	9.28e-05	0.000313	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	9.2e-05	0.00031	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CD36—atherosclerosis	9.13e-05	0.000308	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	9.09e-05	0.000306	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	9.09e-05	0.000306	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	9.09e-05	0.000306	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	9.01e-05	0.000304	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOB—atherosclerosis	9.01e-05	0.000304	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	8.93e-05	0.000301	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	8.86e-05	0.000299	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	8.79e-05	0.000296	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	8.73e-05	0.000294	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	8.71e-05	0.000294	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	8.7e-05	0.000293	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	8.67e-05	0.000292	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—MTHFR—atherosclerosis	8.65e-05	0.000292	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LPL—atherosclerosis	8.6e-05	0.00029	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—atherosclerosis	8.53e-05	0.000288	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARA—atherosclerosis	8.49e-05	0.000286	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOB—atherosclerosis	8.41e-05	0.000284	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	8.36e-05	0.000282	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	8.36e-05	0.000282	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	8.34e-05	0.000281	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	8.28e-05	0.000279	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	8.24e-05	0.000278	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—atherosclerosis	8.23e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AGT—atherosclerosis	8.22e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	8.22e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOB—atherosclerosis	8.17e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	8.15e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	8.11e-05	0.000273	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOE—atherosclerosis	8.05e-05	0.000271	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LPL—atherosclerosis	8.03e-05	0.000271	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	7.99e-05	0.000269	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	7.98e-05	0.000269	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CAV1—atherosclerosis	7.98e-05	0.000269	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOA1—atherosclerosis	7.96e-05	0.000268	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTM1—atherosclerosis	7.95e-05	0.000268	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	7.93e-05	0.000267	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	7.81e-05	0.000263	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LPL—atherosclerosis	7.8e-05	0.000263	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	7.78e-05	0.000262	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	7.73e-05	0.000261	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GPX1—atherosclerosis	7.61e-05	0.000257	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	7.61e-05	0.000256	CbGpPWpGaD
Brimonidine—AOX1—Disease—AKT1—atherosclerosis	7.59e-05	0.000256	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	7.57e-05	0.000255	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	7.54e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CD36—atherosclerosis	7.41e-05	0.00025	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AGT—atherosclerosis	7.36e-05	0.000248	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—AKT1—atherosclerosis	7.32e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	7.32e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PIK3CG—atherosclerosis	7.27e-05	0.000245	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LEP—atherosclerosis	7.21e-05	0.000243	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOE—atherosclerosis	7.21e-05	0.000243	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	7.14e-05	0.000241	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	7.13e-05	0.00024	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	7.07e-05	0.000238	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	7.04e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	7.04e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—atherosclerosis	7.03e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—atherosclerosis	7.01e-05	0.000236	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARA—atherosclerosis	6.89e-05	0.000232	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	6.88e-05	0.000232	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—INS—atherosclerosis	6.88e-05	0.000232	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGT—atherosclerosis	6.87e-05	0.000232	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—AKT1—atherosclerosis	6.84e-05	0.000231	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	6.83e-05	0.00023	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—F2—atherosclerosis	6.8e-05	0.000229	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	6.78e-05	0.000228	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LEP—atherosclerosis	6.73e-05	0.000227	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOE—atherosclerosis	6.73e-05	0.000227	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	6.72e-05	0.000227	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AGT—atherosclerosis	6.68e-05	0.000225	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	6.67e-05	0.000225	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	6.67e-05	0.000225	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	6.66e-05	0.000224	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOE—atherosclerosis	6.54e-05	0.00022	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	6.52e-05	0.00022	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	6.51e-05	0.000219	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAV1—atherosclerosis	6.48e-05	0.000218	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOA1—atherosclerosis	6.47e-05	0.000218	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	6.43e-05	0.000217	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—AKT1—atherosclerosis	6.36e-05	0.000214	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—F2—atherosclerosis	6.35e-05	0.000214	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	6.34e-05	0.000214	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—atherosclerosis	6.31e-05	0.000213	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	6.23e-05	0.00021	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	6.18e-05	0.000208	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—INS—atherosclerosis	6.16e-05	0.000208	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	6.15e-05	0.000207	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	6.08e-05	0.000205	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	6.06e-05	0.000204	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—atherosclerosis	6.03e-05	0.000203	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	5.96e-05	0.000201	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	5.9e-05	0.000199	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	5.82e-05	0.000196	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—INS—atherosclerosis	5.75e-05	0.000194	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	5.72e-05	0.000193	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—atherosclerosis	5.7e-05	0.000192	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	5.66e-05	0.000191	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	5.66e-05	0.000191	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—INS—atherosclerosis	5.59e-05	0.000188	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	5.58e-05	0.000188	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	5.56e-05	0.000188	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—AKT1—atherosclerosis	5.56e-05	0.000187	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—atherosclerosis	5.52e-05	0.000186	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	5.47e-05	0.000184	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	5.47e-05	0.000184	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	5.42e-05	0.000183	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	5.41e-05	0.000182	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	5.4e-05	0.000182	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	5.28e-05	0.000178	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	5.22e-05	0.000176	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—F2—atherosclerosis	5.16e-05	0.000174	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—atherosclerosis	5.12e-05	0.000173	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	5.04e-05	0.00017	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	4.94e-05	0.000166	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—atherosclerosis	4.9e-05	0.000165	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	4.79e-05	0.000161	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	4.73e-05	0.000159	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—INS—atherosclerosis	4.67e-05	0.000157	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	4.63e-05	0.000156	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	4.6e-05	0.000155	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	4.56e-05	0.000154	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	4.52e-05	0.000152	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—atherosclerosis	4.48e-05	0.000151	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	4.47e-05	0.000151	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	4.33e-05	0.000146	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	4.32e-05	0.000146	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	4.29e-05	0.000145	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	4.29e-05	0.000145	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	4.25e-05	0.000143	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	4.21e-05	0.000142	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	4.2e-05	0.000142	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	4.1e-05	0.000138	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	4.05e-05	0.000136	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	4e-05	0.000135	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	3.94e-05	0.000133	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	3.93e-05	0.000132	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	3.89e-05	0.000131	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	3.85e-05	0.00013	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	3.68e-05	0.000124	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.63e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	3.63e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	3.6e-05	0.000121	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	3.57e-05	0.00012	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	3.51e-05	0.000118	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	3.46e-05	0.000116	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	3.44e-05	0.000116	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	3.34e-05	0.000112	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	3.29e-05	0.000111	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	3.25e-05	0.00011	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	3.2e-05	0.000108	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	3.19e-05	0.000107	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.95e-05	9.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.92e-05	9.85e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.79e-05	9.41e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AKT1—atherosclerosis	2.77e-05	9.35e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.71e-05	9.13e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	2.69e-05	9.07e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	2.51e-05	8.47e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	2.48e-05	8.37e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	2.32e-05	7.82e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.25e-05	7.59e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.04e-05	6.88e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.88e-05	6.35e-05	CbGpPWpGaD
